Women who gave birth following fertility treatment had no long-term increased risk of death or major cardiovascular events compared to women who gave birth without fertility therapy, according to new research by the Institute ...
Jul 31, 2013
0
0
Even though a newly recognized cardiomyopathy, which mainly impacts women, is typically treatable, Tako-tsubo cardiomyopathy can also be deadly when compounded by other co-morbidities, such as heart failure, according to ...
Mar 9, 2013
0
0
A stroke treatment developed by researcher Byron Ford at the University of California, Riverside, has moved toward clinical trials.
May 9, 2019
0
3
For children with rare heart conditions such as Kawasaki disease, heart failure or congenital heart defects that increase the risk of blood clots, a daily anti-clotting pill may safely allow them to avoid the frequent injections, ...
Oct 31, 2022
0
13
Adolescents and young adults with advanced heart disease are at high risk of dying in the hospital, often require invasive treatment and experience significant symptoms that impact their quality of life.
May 5, 2023
0
40
(HealthDay)—Integration of pharmacists into team-based care practice models can improve patient outcome, especially in chronic diseases, such as diabetes, according to a report published in the American Medical Association's ...
Sep 4, 2018
0
1
Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart ...
Aug 31, 2020
0
4
Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published online June 26 in JAMA Network Open.
Jul 1, 2024
0
0
The Cardiovascular Surgery Group at Osaka University succeeded in minimally invasive treatment of a patient with acute heart failure due to medical treatment-resistant cardiogenic shock by making use of Impella, a percutaneous ...
Oct 31, 2017
0
0
Cardiologist Bertram Pitt, MD, sees promise in combining two new classes of medication into a treatment regimen for patients with cardiovascular disease. Pitt will discuss the advantages of this treatment plan in his clinical ...
Oct 7, 2019
0
1
